Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN.M)

TLV:TKUN.M Balance Sheet

Financials in millions ILS. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	0	0.03	0.16	6.64	1.76	13.42
Cash & Short-Term Investments	0	0.03	0.16	6.64	1.76	13.42
Cash Growth	-	-81.25%	-97.59%	278.36%	-86.91%	21.58%
Accounts Receivable	0.15	-	3.92	5.72	12.91	9.71
Other Receivables	0.59	0.45	0.09	0.18	0.07	0.45
Receivables	0.73	0.45	4.01	5.89	12.98	10.16
Inventory	0.47	0.1	1.26	9.84	21.11	15.04
Prepaid Expenses	-	0.17	0.55	0.28	-	-
Other Current Assets	0.26	0.54	0.5	1.44	7.62	4.31
Total Current Assets	1.46	1.29	6.48	24.1	43.46	42.93
Property, Plant & Equipment	-	0.21	7.31	29.41	69.21	77.89
Long-Term Investments	-	-	-	4.73	6.93	1.16
Goodwill	-	-	-	-	1.34	18.91
Other Intangible Assets	-	-	9.81	18.34	35.89	48.9
Other Long-Term Assets	-	-	0.41	-	-	-
Total Assets	1.46	1.5	24.01	76.57	156.83	189.78

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2.69	3.05	1.14	3.56	6.99	5.27
Accrued Expenses	-	5.66	6.63	8.5	6.06	5.82
Short-Term Debt	10.2	11.88	10.74	12.52	10.01	10.2
Current Portion of Long-Term Debt	-	-	-	-	-	0.07
Current Portion of Leases	-	0.23	0.56	1.09	1.74	1.57
Current Unearned Revenue	-	-	-	-	1.52	-
Other Current Liabilities	10	-	0.87	2.66	0.88	0.04
Total Current Liabilities	22.89	20.83	19.94	28.33	27.21	22.97
Long-Term Debt	1.49	1.48	1.45	1.48	1.48	1.56
Long-Term Leases	-	0.16	3.5	4.98	6.03	6.45
Other Long-Term Liabilities	-	-	4.47	8.74	5.19	14.98
Total Liabilities	24.38	22.46	29.36	43.53	39.9	45.96

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Additional Paid-In Capital	277.71	277.66	277.46	275.74	265.61	244.31
Retained Earnings	-292.83	-290.83	-274.97	-234.87	-145.99	-97.75
Total Common Equity	-15.12	-13.17	2.48	40.87	119.62	146.56
Minority Interest	-7.8	-7.8	-7.83	-7.83	-2.7	-2.73
Shareholders' Equity	-22.92	-20.97	-5.35	33.04	116.92	143.82
Total Liabilities & Equity	1.46	1.5	24.01	76.57	156.83	189.78

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	11.69	13.75	16.25	20.06	19.26	19.85
Net Cash (Debt)	-11.68	-13.72	-16.09	-13.42	-17.5	-6.43
Net Cash Growth	-	-	-	-	-	-
Working Capital	-21.43	-19.54	-13.46	-4.23	16.25	19.95
Tangible Book Value	-15.12	-13.17	-7.33	22.53	82.39	78.76
Buildings	-	-	56.49	56.49	56.35	54.22
Machinery	-	-	4.45	4.44	4.51	4.63

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 24, 2026

Data Sources Report a data error